Author

Yuxin Xie

Observed name: Yu-Xin Xie

Institutions: Changsha Central Hospital, University of South China

Observed institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Changsha Central Hospital, Fu Wai Hospital, University of South China

ORCID: 0009-0008-6324-1422

Observed ORCID: 0009-0008-6324-1422

OpenAlex ID: A5006079294

Targeted Mitochondrial Drugs for Treatment of Ischemia-Reperfusion Injury

2022 · Guang-Hui Yi, Jin-Fu Peng, et al. · Current Drug Targets · 16

Mitochondria-Associated Organelle Crosstalk in Myocardial Ischemia/Reperfusion Injury

2024 · Hui Yao, Yuxin Xie, et al. · Journal of Cardiovascular Translational Research · 10

Trends of Hypercholesterolemia Change in Shenzhen, China During 1997–2018

2022 · Ke Peng, Weicong Cai, et al. · Frontiers in Public Health · 7

Insight into modulators of sphingosine-1-phosphate receptor and implications for cardiovascular therapeutics

2024 · Yu-Xin Xie, Hui Yao, et al. · Journal of drug targeting · 5

Impacts of birthplace and complications on the association between cold exposure and acute myocardial infarction morbidity in the Migrant City: A time-series study in Shenzhen, China

2022 · Ke Peng, Wenhua Yan, et al. · The Science of The Total Environment · 5

Trends of mean systolic and diastolic blood pressure among adults in Shenzhen, China, 1997–2018: findings from three rounds of the population-based survey

2024 · Ke Peng, Weicong Cai, et al. · BMJ Open · 3

Therapeutic implication of targeting mitochondrial drugs designed for efferocytosis dysfunction

2024 · Wan-Ting Liu, Chao-Quan Li, et al. · Journal of drug targeting · 2

Association Between Solid Fuel Use and the Risk of Hypertension in China

2023 · Ziwei Fu, Shuang Wang, et al. · Journal of Occupational and Environmental Medicine · 2

A Case of Langerhans Cell Histiocytosis With a Neck Mass as the First Symptom

2025 · Yuxin Xie, Xiaoming Kang, et al. · Clinical Case Reports

Works count: 9

Citation count: 50

H-index: 5

I10-index: 2